Inventor
Robert Deziel
Inventor
Mont-Royal, CA
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds23%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds13%
C07KPeptides8%
C07HSugars3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
C12NMicroorganisms or enzymes2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
9,636,298'Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs'20179,193,749'Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors'20159,096,565'Inhibitors of histone deacetylase'20158,796,330'Inhibitors of histone deacetylase and prodrugs thereof'20148,759,400'Histone deacetylase inhibitors for enhancing activity of antifungal agents'20148,673,911'Inhibitors of histone deacetylase'20148,598,168'Inhibitors of histone deacetylase'20138,399,452'Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors'20137,790,729'Inhibitors of VEGF receptor and HGF receptor signaling'20107,521,420'Macrocyclic antagonists of the motilin receptor'20097,273,861'Non-nucleoside reverse transcriptase inhibitors'20077,105,510'Non-nucleoside reverse transcriptase inhibitors'20066,716,836'Non-nucleoside reverse transcriptase inhibitors'20046,706,706'Non-nucleoside reverse transcriptase inhibitors'20046,673,791'Non-nucleoside reverse transcriptase inhibitors'20046,313,095'Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain'20016,242,439'Azetidinone derivatives for the treatment of HCMV infections'20016,239,125'Azetidinone derivatives for the treatment of HCMV infections'20016,211,170'Azetidinone derivatives for the treatment of HCMV infections'20015,846,941'Isosteric antiherpes peptide derivatives II'19985,830,864'Antiherpes peptide derivatives having a ureido n-terminus'19985,700,780'Antiviral peptide derivatives having a 2-oxoalkyl amino acid side chain'19975,484,771'Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus'19965,476,841'Inhibitors of herpes viral ribonucleotide reductase'19955,380,727'Synergistic combination for treating herpes infections'19954,841,043'Stereoselective synthesis of 1-.beta.-alkyl carbapenem antibiotic intermediates'19894,788,282'Deprotection of allylic esters and ethers'1988Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1988Based in Quebec, CA· patent location history
1989Based in St-Lambert, CA· patent location history
1995–2007Based in Mont-Royal, CA· patent location history
1997–2007Patents assigned to BOEHRINGER INGELHEIM CA LTD (11)· patent assignee history
2009–2017Based in Mount Royal, CA· patent location history
2010–2017Patents assigned to METHYLGENE INC (9)· patent assignee history
2013–2015Patents assigned to DEZIEL ROBERT (5)· patent assignee history
2013–2015Patents assigned to LEIT SILVANA (4)· patent assignee history
2014–2015Patents assigned to AJAMIAN ALAIN (4)· patent assignee history
2014Based in Annapolis Royal, CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BOEHRINGER INGELHEIM CA LTD | 11 | 1997–2007 |
| METHYLGENE INC | 9 | 2010–2017 |
| DEZIEL ROBERTself | 5 | 2013–2015 |
| AJAMIAN ALAIN | 4 | 2014–2015 |
| LEIT SILVANA | 4 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mont-Royal, CA | 15 | 1995–2007 |
| Mount Royal, CA | 9 | 2009–2017 |
| Annapolis Royal, CA | 1 | 2014 |
| St-Lambert, CA | 1 | 1989 |
| Quebec, CA | 1 | 1988 |